药物合成结晶技术相关研究

桑光明

现代工业与技术 ›› 2025, Vol. 2 ›› Issue (11) : 7 -9.

PDF (991KB)
现代工业与技术 ›› 2025, Vol. 2 ›› Issue (11) : 7 -9. DOI: 10.12349/mit.v2i11.9378

药物合成结晶技术相关研究

作者信息 +

Research on Crystallization Technology for Drug Synthesis

Author information +
文章历史 +
PDF (1014K)

摘要

经济社会的迅速发展以及科技研究的不断深入使得药物生产技术也得到了长足发展。药物合成结晶作为药物生产中十分重要的组成部分,结晶质量直接影响药物疗效与临床应用,因此近几年来药物合成结晶技术也成为了医药行业研究的技术重点。如何合成更高纯度的结晶、保障药物活性是药物合成结晶技术研究中需主要分析的问题,可以从测定溶解度曲线、测定介稳区宽度、研究结晶动力学三个环节做好药物合成结晶过程的把控,配合结晶技术的应用和技术控制提高药物合成结晶技术的应用成效。

Abstract

The rapid development of socio-economic progress and continuous advancement in scientific research have significantly propelled pharmaceutical production technologies. As a critical component in drug manufacturing, drug synthesis crystallization plays a pivotal role in determining therapeutic efficacy and patient outcomes. Consequently, this technology has become a key focus in pharmaceutical industry research in recent years. Key challenges in crystallization technology include achieving higher purity crystals and ensuring drug activity. Effective process control can be achieved through three critical steps: dissolution curve analysis, mesophilic zone width measurement, and crystallization kinetics studies. Integrating crystallization techniques with precision process controls will enhance the practical application outcomes of pharmaceutical synthesis crystallization technologies.

关键词

药物合成结晶技术 / 结晶过程控制 / 结晶工艺优化 / 药物纯度

Key words

Drug synthesis crystallization technology / Technical process / Technical control / Drug production

引用本文

引用格式 ▾
桑光明. 药物合成结晶技术相关研究[J]. 现代工业与技术, 2025, 2(11): 7-9 DOI:10.12349/mit.v2i11.9378

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Paul, E. L., et al. (2005). "Organic crystallization processes." Powder technology 150(2): 133-143.

[2]

Nordstrom, F. L., et al. (2023). "Prevalence of Impurity Retention Mechanisms in Pharmaceutical Crystallizations." Organic Process Research & Development 27(4): 723-741.

[3]

Herman, C., et al. (2012). "Use of in Situ Raman, FBRM, and ATR—FTIR Probes for the Understanding of the Solvent—Mediated Polymorphic Transformation of II—I Etiracetam in Methanol." Organic Process Research & Development 16(1): 49-56.

[4]

刘培鸿, 丁朝旺, 石艳彩, . 基于连续流微反应—结晶耦合技术的阿托伐他汀钙母核绿色合成工艺研究 [J]. 化学研究与应用, 2026, 38 (02): 450-455.

[5]

张苗苗, 何蕙利, 屈撑囤. 碳酸氢钠结晶抑制剂的合成与性能评价 [J]. 石油化工应用, 2025, 44 (12): 6-9.

[6]

杨超, 刘红宇, 钟家春, . 高分子量结晶性聚芳醚腈的合成与性能 [J]. 塑料工业, 2025, 53 (10): 13-18+70.

AI Summary AI Mindmap
PDF (991KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/